Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Clinical trial NCT05789667 · RECRUITING
Trial details
- NCT number
- NCT05789667
- Sponsor
- Regina Elena Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-27
- Primary completion
- 2024-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.